Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are Bacillus thuringiensis strains like any other Bacillus cereus strains? Phenotypic-based tools to locate Bacillus thuringiensis in the diversity of the Bacillus cereus sensu lato group.

Research in microbiology·2023
Same author

Lactobacilli intra-tracheal administration protects from <i>Pseudomonas aeruginosa</i> pulmonary infection in mice - a proof of concept.

Beneficial microbes·2020
Same author

Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways.

Current gene therapy·2016
Same author

Dietary exposure to aflatoxins, ochratoxin A and deoxynivalenol from a total diet study in an adult urban Lebanese population.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2014
Same author

Effects of beauvericin, enniatin b and moniliformin on human dendritic cells and macrophages: an in vitro study.

Toxicon : official journal of the International Society on Toxinology·2013
Same author

Co-exposure of Fusarium mycotoxins: in vitro myelotoxicity assessment on human hematopoietic progenitors.

Toxicon : official journal of the International Society on Toxinology·2012
Same journal

Retraction notice to "Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro" [Toxicology 283 (2011) 129-139].

Toxicology·2026
Same journal

Crystalline silica particles exposure modulated miRNA expression profiles in human macrophage-like THP-1 cells.

Toxicology·2026
Same journal

Sex-specific cellular and molecular mechanisms of PFAS-induced reproductive toxicity.

Toxicology·2026
Same journal

Neurotoxicity and Mechanisms of Deltamethrin and Its Metabolite 3-PBA in HT22 Cells.

Toxicology·2026
Same journal

Polystyrene nanoplastics impair epithelial barrier establishment and modulate extracellular vesicle release in human bronchial cells cultured at the air-liquid interface.

Toxicology·2026
Same journal

Effects of HFPO-DA (GenX) exposure on placental glycolysis and metabolic microenvironment in pregnant rats.

Toxicology·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Stem cells in myelotoxicity.

D Parent-Massin1, N Hymery, Y Sibiril

  • 1Laboratoire de Toxicologie Alimentaire et Cellulaire, EA 3880, Université Europeene de Bretagne, Université de Brest, 29200 Brest, France. parentm@univ-brest.fr

Toxicology
|November 4, 2009
PubMed
Summary
This summary is machine-generated.

Myelotoxicity, or bone marrow failure, can be detected using hematopoietic progenitor clonogenic assays. These assays, including CFU-GM, BFU-E, and CFU-MK, are vital for assessing xenobiotic-induced damage to blood cell formation.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Related Experiment Videos

Last Updated: Jun 19, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Area of Science:

  • Toxicology
  • Hematology
  • Cell Biology

Background:

  • Myelotoxicity is bone marrow failure caused by xenobiotics impacting hematopoiesis.
  • Hematopoiesis involves pluripotent hematopoietic stem cells (PHSCs) and stromal cells within a niche.
  • Understanding this complex system is crucial for evaluating xenobiotic effects.

Purpose of the Study:

  • To review the designs and applications of hematopoietic progenitor clonogenic assays in myelotoxicology.
  • To highlight the utility of these assays in detecting xenobiotic-induced damage.
  • To provide a comprehensive overview for researchers in the field.

Main Methods:

  • Focuses on three key clonogenic assays: Colony Forming Unit Granulocyte and Macrophage (CFU-GM), Burst Forming Unit Erythroid (BFU-E), and Colony Forming Unit Megakaryocyte (CFU-MK).
  • Discusses the application of these assays across various species, including murine, mammalian, and human.
  • Covers the detection of myelotoxicity induced by chemicals, drugs, food, and environmental contaminants.

Main Results:

  • Clonogenic assays are effective tools for identifying myelotoxicity.
  • These assays can detect damage to various blood cell lineages (granulocyte, macrophage, erythroid, megakaryocyte).
  • The review details the practical designs and applications of these assays.

Conclusions:

  • Hematopoietic progenitor clonogenic assays are essential for assessing myelotoxicity.
  • These assays provide a reliable method for evaluating the impact of xenobiotics on blood cell production.
  • The reviewed methods are applicable to a wide range of toxicological studies.